The holy grail: pan-cancer-targeting T cells
Crowther and Dolton et al. identified an unconventional human T cell clone capable of killing many different types of cancer in vitro in an HLA-independent fashion while sparing healthy cells. Using genome-wide CRISPR-Cas9 screening, the researchers showed that the T cell clone recognized the ubiquitously expressed, mostly monomorphic, MHC-I-related protein MR1 on the surface of cancer cells when MR1 was loaded with a yet unidentified cancer-specific or cancer-associated ligand. Adoptive transfer of this T cell clone into immunodeficient NSG mice with leukemia reduced tumor burden and increased survival.
Discovery of a Pan-Cancer Killing T Cell
Differences in glycolysis pathways between normal cells and cancer
A Road Map to Personalizing Targeted Cancer Therapies Using
A systematic study of novel drug delivery mechanisms and treatment
Frontiers Adoptive NK Cell Therapy - a Beacon of Hope in
Pan-cancer T cell atlas links a cellular stress response state to
Cancers, Free Full-Text
Pan-cancer T cell atlas links a cellular stress response state to
NIH Completes PanCancer Atlas - NCI
Frontiers Platelet detection as a new liquid biopsy tool for
Novel strategies for cancer immunotherapy: counter-immunoediting
Michael G King Jr (@MichaelGKingJr) / X